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Increasing evidence suggests that regulation of apoptosis in infected cells is associated with several viral infections. The
gammaherpesvirus bovine herpesvirus 4 (BHV-4) has been shown to harbor genes with antiapoptotic potentialities. However,
here we have demonstrated that productive infection of adherent, permissive cell lines by BHV-4 resulted in a cytopathic
effect characterized by induction of apoptosis. This phenomenon was confirmed using different techniques to detect
apoptosis and using different virus strains and cell targets. Apoptosis induced by BHV-4 was inhibited by (1) treatment with
doses of heparin, which completely inhibited virus attachment and infectivity; (2) UV treatment, which completely abrogated
infectivity; and (3) treatment with a dose of phosphonoacetic acid, which blocked virus replication. Virus-induced apoptosis
was associated with a down-regulation of Bcl-2 expression and was reduced by Z-VAD-FMK, but not by Z-DEVD-FMK
(caspase-3-specific) caspase inhibitors. Inhibition of apoptosis by Z-VAD-FMK treatment during infection did not modify virus
yield. Therefore, despite the presence of antiapoptotic genes in its genoma, BHV-4 could complete its cycle of productive
infection while inducing apoptosis of infected cells. This finding might have implications for the pathobiology of BHV-4 and
other gammaherpesviruses in vivo. © 2000 Academic PressINTRODUCTION
Bovine herpesvirus 4 (BHV-4) is a member of the
Gammaherpesvirinae subfamily of herpesviruses. It
belongs to the g-2-herpesviruses on the basis of its
thymidine kinase activity and its genomic similarity to
other viruses of this subgroup, such as herpesvirus
Saimiri (HVS) and human herpesvirus 8 (HHV-8), the
ethiological agent of Kaposi’s sarcoma in humans
(Bublot et al., 1991, 1992; Goltz et al., 1994; Lomonte et
l., 1992, 1996; Thiry et al., 1992). Unlike other herpes-
iruses, BHV-4, originally isolated by Bartha et al.
1966), is characterized by an unusually wide host
ange both in vivo and in vitro. In fact, it has been
demonstrated that BHV-4 strains can infect American
bison, African buffalo, and goats as well as nonrumi-
nant species such as the lion and, under particular
conditions, the cat (Kruger et al., 1990; Moreno-Lopez
et al., 1989; Rossiter et al., 1989; Todd and Storz, 1983).
In vitro, BHV-4 replicates in a variety of cell cultures,
including established primary kidney cell cultures
from cattle, sheep, goats, dogs, cats, rabbits, pigs, and
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27chicken as well as in various cell lines from these and
other species, including humans, as recently demon-
strated (Egyed, 1998).
Viruses have been found to have selected, during
evolution, specific mechanisms to escape host de-
fense, using different strategies (reviewed by Ploegh,
1998). Apoptosis, the form of cell death initially de-
scribed by Kerr et al. (1972), could have been selected
during evolution as a highly conservative nonspecific
host response to limit virus spread, thus contributing
to the control of the infectious focus (reviewed in
O’Brien, 1998; Razvi and Welsh, 1995; Shen and Shenk,
1995). This seems to be the reason why a number of
viruses have genes able to sustain inhibitory effects
on apoptosis upon infection (reviewed in Teodoro and
Branton, 1997). It was demonstrated that BHV-4 carries
a gene which encodes a protein that inhibits Fas- and
TNFR1-induced apoptosis by interacting with
caspase-8 (Wang et al., 1997). In addition, a bcl-2
homolog, whose antiapoptotic activity was recently
demonstrated (Bellows et al., 2000), was found in the
BHV-4 genome. The products of these genes are
strictly related to proteins encoded by other g-2-her-
pesviruses, such as HHV-8. However, no information is
available on the real ability of these viruses to regulate
apoptosis following productive infection. Obviously, it
is difficult to obtain this information studying viruses,
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28 SCIORTINO ET AL.such as HHV-8, that cannot yet be grown efficiently in
cell culture. Since increasing evidence would indicate
that several viruses could simultaneously carry genes
able to both block and induce apoptosis (Teodoro and
Branton, 1997), we have used the availability of an
efficient experimental model of infection in vitro for
BHV-4 to investigate whether the presence of anti-
apoptotic genes in the genoma of a g-2-herpesvirus
ffectively and invariably leads to the inhibition of
poptosis during productive infection.
RESULTS
ovine herpesvirus 4, strain LVR 140, induced
poptosis in permissive cell lines
To define whether infection by BHV-4 could be as-
ociated with the ability of the virus to interact with
poptotic signals, we investigated the characteristics
f cell death caused by infection with the LVR 140
train of the virus in the BS/BEK cell line, derived from
ovine embryo kidney, as a model of a permissive cell
ine. In this cell line, infected at a multiplicity of infec-
ion (m.o.i.) of 10 PFU/cell, the cytopathic effect ap-
eared on Day 2 postinfection (p.i.) and reached a
assive effect on Days 3–4 p.i., when most of the cells
ere seen to be detached from the bottom of the flask
nd were floating in the supernatant. Results showed
marked increase in the percentage of apoptotic cells
FIG. 1. Fluorescence microscopy analysis of BHV-4-infected cells. BS
strain of BHV-4, at a m.o.i. of 10 PFU/cell, were analyzed 48 h p.i. afte
samples, many cells show the morphological characteristics of apoptos
beads. Magnification 3400.ollowing LVR 140 infection, when compared with con-
rol cells, which were uninfected or mock-infected,sing both acridine orange and Hoechst staining. In
he representative experiment shown in Fig. 1, the
evel of apoptosis, detected by acridine orange stain-
ng, reached about 90% 48 h p.i. Similar, but less-
ronounced, effects using the same dose of virus
noculum and at the same time p.i., were observed in
he AU-BEK (Fig. 1) and in the MDBK (data not shown)
HV-4-permissive cell lines. Uninfected controls
howed low levels of spontaneous apoptosis (,5%),
as did mock-infected cells (data not shown). Similar
effects were obtained when Hoechst was used as a
DNA-staining dye (data not shown).
To confirm the above-reported results, we utilized
flow cytometry analysis of isolated nuclei, according to
a technique to detect apoptosis, which allows us to
distinguish apoptosis from necrosis and viability, as
we recently demonstrated (Matteucci et al., 1999). Re-
sults unconfutably confirmed morphological analysis.
In the experiment shown in Fig. 2, the percentage of
hypodiploid nuclei obtained from cultures infected
with a dose of 10 PFU/cell of LVR 140 was still rather
low 24 h after infection (17%, Fig. 2C), while it rose to
81% 48 h after infection (Fig. 2D). Moreover, to verify
whether necrosis could be distinguished from apopto-
sis and viability in BS/BEK using our technique, com-
bined flow cytometry analysis for red fluorescence and
forward-scatter (FSC) versus side-scatter (SSC) was
applied in other experiments, in parallel to control
nd AU-BEK cells, mock-infected or infected with the LVR 140 reference
ng with the fluorescent DNA-binding dye acridine orange. In infected
nuclei resembling one or more groups of featureless, bright, spherical/BEK a
r stainiuntreated cells, to cells that were heat-shocked at
60°C for 1 h to induce necrosis and to cells infected by
29APOPTOSIS IN PERMISSIVE CELLS BY BHV-4BHV-4 to induce apoptosis. As shown in Fig. 3, nuclei
from viable cells (Fig. 3A) and from heat-shocked ne-
crotic cells (Fig. 3C) fell into the same fluorescence
emission peaks, while many of those from infected
cells fell into the typical peak of hypodiploid apoptotic
nuclei (Fig. 3E). However, using the FSC/SSC analysis,
nuclei derived from BS/BEK cells in which necrosis
was induced (Fig. 3D) were remarkably different from
nuclei derived from viable or BHV-4-infected cells
(Figs. 3B and 3F, respectively). In fact, they showed
higher FSC and SSC values, as we previously de-
scribed for lymphoid cells (Matteucci et al., 1999).
Nuclei with similar characteristics, typical of necrotic
cells, were not detected in BHV-4-infected samples.
Apoptosis in BS/BEK cells infected with LVR 140
was also evaluated using the TUNEL technique, an
assay able to directly detect DNA fragmentation at the
FIG. 2. Induction of apoptosis by BHV-4-infection in BS/BEK cells, det
control, mock-infected cultures (A, B) or from cells infected with BHV-4
treatment with a hypotonic solution containing detergent and propid
boundaries among the peaks of diploid and hypodiploid nuclei and
maintained for all other samples. The numbers in the cytograms repres
from which debris were excluded.single-cell level. In the experiment illustrated in Fig. 4,
24 h after infection at a m.o.i. of 5 PFU/cell, we ob-tained 13% positive apoptotic cells (Fig. 4C) and 63%
positive apoptotic cells at 48 h p.i. (Fig. 4D), in com-
parison with 1 and 2% positive cells from mock-in-
fected cultures at 24 or 48 h p.i., respectively (Figs. 4A
and 4B) and 98% in the positive control consisting of
DNase I-treated cells (not shown). Figure 5 summa-
rizes the results of four independent experiments in
which apoptosis induced by LVR 140 at various PFU/
cell ratios was evaluated by morphological analysis of
cells after staining with acridine orange, as described
above. Low levels of apoptosis were detected using
this technique at 24 h following infection at all m.o.i.
tested as well as at a m.o.i. of 1 PFU/cell at 48 h p.i.,
while at 72 h p.i. cultures infected at all m.o.i. tested
showed a high percentage of characteristic apoptotic
cells in a dose-dependent fashion. Variability from
experiment to experiment was rather high, as indi-
y flow cytometry. After 24 h (A, C) and 48 h of culture (B, D), nuclei from
LVR 140, at a m.o.i. of 10 PFU/cell (C, D) were isolated and stained by
ide and analyzed by flow cytometry. The dashed lines indicate the
ably of debris, which were arbitrarily set on untreated samples and




ent thecated by standard deviation values. Nevertheless, in-
duction of apoptosis was invariably detected following
30 SCIORTINO ET AL.FIG. 3. Combined flow cytometry analysis by red fluorescence (A, C, E) and by two-parameter FSC/SSC (B, D, F) analysis of nuclei from viable,
necrotic, or apoptotic BS/BEK cells. BS/BEK cells were left either untreated (A, B), heat shocked at 60°C for 1 h in a water bath to induce necrosis
(C, D), or infected with LVR 140 at a m.o.i. of 10 PFU/cell to induce apoptosis 48 h after infection (E, F) and stained as described in Fig. 2. The dashed
lines in (A), (C), and (E) indicate the boundaries among the peaks of diploid and hypodiploid nuclei and presumably of debris, which were arbitrarily
set on untreated samples and maintained for all other samples. The numbers in the cytograms represent the percentages of hypodiploid nuclei, based






31APOPTOSIS IN PERMISSIVE CELLS BY BHV-4infection and was dependent on the dose of virus
inoculum and on the length of time of culture following
infection.
Induction of apoptosis by BHV-4 in BS/BEK cells was
associated with significant levels of viral production
and was not restricted to the LVR-140 strain
We were then interested to confirm whether cell death
by apoptosis was compatible with a significant level of
viral production. To this purpose, the infecting activity of
supernatants from LVR 140-infected BS/BEK cells was
evaluated by detecting plaque formation at Day 7 in the
same cell line. Figure 6A shows a time course of virus
yield in supernatants following exposure to LVR 140 for
1 h at a m.o.i. of 10 PFU/ml. Productive infection was
clearly demonstrated by a progressive increase in re-
leased virus with the ongoing of the culture. Active rep-
lication of LVR 140 in BS/BEK cells was also confirmed by
using a BHV-4-specific monoclonal antibody and fluores-
cence microscopy. Using this technique to detect virus
FIG. 4. Apoptosis of BHV-4-infected BS/BEK cells, detected using the
f 5 PFU/cell, was analyzed by flow cytometry using the TUNEL techn
8 h p.i. (B), respectively. Infected cultures at 24 h p.i. (C) and at 48 h p.i.
nd positive cells, which were arbitrarily set in control samples inc
ITC-dUTP samples showed less than 1% positive cells (not shown) a
amples. The numbers in the cytograms represent the percentages ofreplication, the first appearance of positivity for BHV-4
proteins was evident at 12 h p.i., with a high percentageof positive cells for viral proteins at 24 h p.i. and almost
all positive cells at 48 h p.i. (Fig. 6B). Simultaneous
detection of viral protein expression and apoptosis still
showed a very low level of apoptotic cells at 24 h p.i. (Fig.
6B). Conversely, at 48 h p.i. cells showed the character-
istics of both apoptotic and infected cells (Fig. 6B). Dou-
ble-fluorescence observation demonstrated that part of
the cells positive for virus-specific proteins was still
apparently intact, whereas apoptosis was never ob-
served in virus-protein-negative cells (data not shown).
Moreover, to verify whether induction of apoptosis in
permissive cells was dependent on the particular strain
of BHV-4 utilized, the effects of LVR 140 were compared
with those obtained using the BHV-4/F1 strain. Both
strains were able to induce apoptosis following infection
of BS/BEK cells (data not shown).
Treatment with heparin or with an inhibitor of virus
replication and exposure of BS/BEK cells to UV-
inactivated LVR 140, inhibited virus-induced apoptosis
technique. Apoptosis of BS/BEK cells infected with LVR 140 at a m.o.i.
r detecting DNA breaks. Mock-infected cultures at 24 h p.i. (A) and at
spectively. The dashed lines indicate the boundaries between negative
with FITC-dUTP solution alone, without the addition of Tdt. Control
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32 SCIORTINO ET AL.whether treatment with heparin, which prevents virion
attachment, or exposure of BS/BEK cells to UV-inacti-
vated LVR 140, which allows attachment but prevents
infectivity, or addition of phosphonoacetic acid (PAA), a
well-known inhibitor of herpesvirus DNA polymerase,
could interfere with the induction of apoptosis. Heparin
addition prevented apoptosis at 48 h p.i. In particular, at
doses of 100 and 500 U/ml, apoptosis (as well as virus
infection) was completely inhibited in comparison with
FIG. 5. Kinetic- and dose-dependency of BHV-4-induced apoptosis in
ermissive cells. Apoptosis induced by BHV-4, strain LVR 140, following
nfection at indicated PFU/cell ratios, was evaluated by calculating the
ercentage of cells showing nuclear morphology of apoptosis using
luorescence microscopy analysis of cells after staining with the DNA-
inding dye acridine orange. Results are expressed as means 6 SD
rom four independent experiments. All comparisons among the mock-
nfected group and groups infected with a different m.o.i. at the same
ime were significant except for: all groups at time 24 h, control versus
.o.i. 1, and m.o.i. 10 versus m.o.i. 100 at time 48 h. All comparisons
mong groups infected with the same m.o.i. at different times were
ignificant except for: control mock-infected groups at any time, time
4 h versus time 48 h at a m.o.i. of 1, time 48 h versus time 72 h at a
.o.i. of 10 and 100.
FIG. 6. Time course of virus production, viral protein expression,
supernatants by BS/BEK cells was titrated by plaque assay soon after t
with LVR 140 at a m.o.i. of 10 PFU/cell. (B) Expression of viral proteins
and apoptosis, calculated by counting the percentage of cells showing n
were evaluated by fluorescence microscopy in the same infected cult
obtained from triplicate cultures in one of three experiments performed with si
except for virus production, time 0 against time 12 h.control cultures (data not shown). Moreover, as evalu-
ated by fluorescence microscopy following acridine or-
ange staining, PAA prevented LVR 140-induced apopto-
sis at 48 h p.i. in a dose-dependent manner (Fig. 7A). The
same experiments showed that PAA by itself induced a
low level of apoptosis, but only at the highest dose of 300
mg/ml. In this case, too, simultaneous detection of viral
replication by IFA showed a direct, dose-dependent cor-
relation between prevention of apoptosis and inhibition
of viral protein expression (Fig. 7A). We further investi-
gated the relationships between apoptosis and virus
replication. After UV irradiation of the virus we compared
the inactivation of infectivity with that of apoptosis-induc-
ing activity. As shown in Fig. 7B both infectivity and
apoptosis-inducing activity were similarly suppressed by
increasing exposure to UV light.
LVR 140-induced apoptosis in BS/BEK cells was
associated with a down-modulation of Bcl-2 and was
reduced by the caspase inhibitor Z-VAD-FMK
Expression of the bcl-2 gene is one of the mechanisms
associated with the modulation of cell apoptosis during
viral infections (Levine et al., 1996; Olsen et al., 1996).
Using flow cytometry, we thus analyzed Bcl-2 protein
cellular levels in BS/BEK cells following LVR 140 infec-
tion. Results showed an evident down-modulation of
Bcl-2 protein in most of the infected cells in experimental
conditions able to induce apoptosis (Fig. 8). No down-
regulation of Bcl-2 was observed at 24 h p.i. (data not
shown). Moreover, to obtain further information on the
mechanisms regulating BHV-4-induced apoptosis, the
possible involvement of the caspase cascade was inves-
tigated by adding synthetic, cell-permeable, noncleav-
able peptide analogs of caspase substrates to infected
optosis in BS/BEK cells infected with BHV-4. (A) Virus released in
val of virus inoculum (time 0) and at 12, 24, 36, and 48 h after infection
ing staining with a BHV-4-specific commercial antibody (histograms),
morphology of apoptosis following staining with acridine orange (line),





















33APOPTOSIS IN PERMISSIVE CELLS BY BHV-4and control cultures, to irreversibly inhibit protease ac-
tivity. As shown in Fig. 9A, Z-VAD-FMK, but not Z-DEVD-
FMK, significantly reduced apoptosis of infected cultures
in comparison with control-treated cultures at 48 h p.i.
Moreover, Fig. 9B shows that daily treatment with a dose
of Z-VAD-FMK able to completely block apoptosis, did not
substantially alter virus yield, measured as PFU/ml in
supernatants from infected cultures, during 6 days of
culture.
DISCUSSION
It has been postulated that apoptosis represents a
well-conserved ancestral form of resistance to virus in-
fection. A number of studies, in fact, have demonstrated
that viruses belonging to a variety of families, particularly
those characterized by persistence, should harbor, in
their genomes, genes that are able to counteract apop-
totic mechanisms (Aubert and Blaho, 1999; Bellows et al.,
2000; Galvan and Roizman, 1998; Galvan et al., 1999;
erome et al., 1998, 1999; Koyama and Miwa, 1997; Leo-
ardi and Roizman, 1996). BHV-4 as well as other g-2-
erpesviruses have been shown to possess such anti-
poptotic machinery (Cheng et al., 1997; Derfuss et al.,
1998; Hu et al., 1997; Sarid et al., 1997; Thome et al., 1997;
ang et al., 1997). However, results reported in the
resent study demonstrate that apoptosis was the only
etectable form of cytopathic effect in several permissive
ell lines for BHV-4.
Recently, another member of the Herpesviridae family,
FIG. 7. Effect of phosphonoacetic acid (PAA) and UV treatment on apo
(histograms) and percentage of viral-protein-positive cells (line), evalua
cells showing nuclear morphology of apoptosis after staining with acrid
commercial antibody, respectively, in BS/BEK cells infected with BHV-4,
at the indicated doses. Apoptosis was also detected in control uninfe
cultures in one of the four experiments performed with similar results.
37.5 mg/ml versus PAA 75 mg/ml, PAA 150 mg/ml versus PAA 300 mg/m
or: PAA 150 mg/ml versus PAA 300 mg/ml, PAA 18.7 mg/ml and PAA 0 m
(histograms) and percentage of viral-protein-positive cells (line), evalu
PFU/cell with BHV-4, strain LVR 140, inactivated by increasing time of e
Data from one of the two experiments performed with similar results abovine herpesvirus 1 (BHV-1), has been shown to cause
apoptosis in vitro (Devireddy and Jones, 1999; Hanon et
H
cal., 1997, 1998). Indeed, some similarities exist between
cell death associated with infection by the two bovine
herpesviruses. First, in both BHV-1 and BHV-4 infections,
cells do not undergo apoptosis early after virus expo-
sure, but in a later phase, i.e., starting 24–36 h following
infection. Second, in both BHV-4 and BHV-1 infection, in
vitro apoptosis is associated with a true productive cycle,
with a high level of virus release, and cannot be effi-
ciently induced by inactivated virus. Finally, induction of
apoptosis by both BHV-1 and BHV-4 is caspase-depen-
dent and can be greatly inhibited using the caspase
inhibitor Z-VAD-FMK. However, when Z-VAD-FMK was
used to reduce apoptosis caused by BHV-1, a significant
increase in virus yield was observed. In contrast, inhibi-
tion of apoptosis using the same treatment did not mod-
ify virus yield in BHV-4-infected cells, unlike that also
observed for other viruses (Chinnaiyan et al., 1997; Chiou
and White, 1998). This distinction could be related to
differences in the virus replication cycle of the two sub-
families of herpesviruses. In contrast with alphaherpes-
viruses, members of the Gammaherpesvirinae subfamily
cause infections that usually occur without production of
infectious progeny (Roizman and Sears, 1996).
Interestingly, we have shown here for the first time that
even when a productive infection of a g-2-herpesvirus
oes occur, as in the case of BHV-4, it seems to be
ssociated with apoptosis and not with a lytic phase,
espite the presence of antiapoptotic genes. Three ex-
erimental findings reported in studies concerning
and viral protein expression in cells infected with BHV-4. (A) Apoptosis
h p.i. using fluorescence microscopy, by calculating the percentage of
nge or percentage of positive cells after staining with a BHV-4-specific
VR 140, at a m.o.i. of 10 PFU/cell and left untreated or treated with PAA
ells. Results are expressed as means 6 SD obtained from triplicate
l comparisons among sample groups were significant except for: PAA
tosis, comparisons among sample groups were not significant except
ntreated control) versus all other groups. (B) Percentage of apoptosis
48 h p.i. as reported in (A), in BS/BEK cells infected at a m.o.i. of 10
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34 SCIORTINO ET AL.of HHV-8 infection in vitro (Schultz, 1998). Recently, this
ifficulty was partly overcome by using experimental
tratagems which, at least in one case, allowed re-
earchers to detect apoptosis in infected cells (Friborg et
l., 1998). Thus, it is possible to hypothesize that difficulty
n finding a good experimental cell model permissive to
HV-8 could be because of the apoptosis-inducing ca-
acity of the virus. The second finding is that recent
esults suggest that chemical induction of HHV-8 DNA
eplication and transcription in primary effusion lym-
homa cell lines overlaps with cell death by apoptosis
Yu et al., 1999). Investigators have attributed apoptosis
o chemical treatment, but we cannot exclude that ex-
ression of viral genes contributes to the phenomenon.
inally, it has recently been demonstrated that apoptosis
s well detected in early Kaposi’s sarcoma lesions, i.e., in
phase which could precede the latency of HHV-8 in-
ection, while it is practically absent in late-stage lesions,
hen expression of K13/v-FLIP gene of HHV-8 increases
Sturzl et al., 1999).
Regarding the mechanisms involved in BHV-4-induced
poptosis, our results raise several points worthy of
FIG. 8. Bcl-2 levels in BS/BEK cells following infection with BHV-4. B
or mock infected (MOCK INFECTED). After 48 h p.i. flow cytometry ana
an FITC-conjugated monoclonal antibody against human Bcl-2 (Bcl-2) o
lines indicate reference boundaries, which were arbitrarily set for the s
anti-Bcl-2-stained samples. Similar results were obtained in four indeponsideration. The first is that we observed a strict cor-
elation between the suppression of apoptosis-inducingactivity and that of infectivity, as shown by experiments
with heparin, PAA, or UV treatment. This distinguishes
apoptosis induced by BHV-4 from that caused in lym-
phoid or monocytoid cells by the members of Alphaher-
pesvirinae subfamily bovine herpesvirus 1 and herpes
simplex 2, which have been demonstrated to maintain, at
least in part, their ability to induce apoptosis following
UV inactivation (Hanon et al., 1996; Mastino et al., 1997).
As a consequence, BHV-4 should not have apoptosis-
inducing structural proteins at all or, alternatively, should
concomitantly harbor one or more highly active apopto-
sis-blocking molecules in its virion. Expression of viral
genes in the late phase of BHV-4 infection could modify
this initial apoptosis-blocking balance. The second con-
sideration concerns the role of caspases, key mediators
of apoptosis (reviewed in Cohen, 1997; Porter and Jan-
icke, 1999; Salvesen and Dixit, 1997). We found that the
caspase inhibitor Z-VAD-FMK almost completely inhib-
ited apoptosis caused by BHV-4, indicating that activa-
tion of the caspase cascade is not dispensable in virus-
induced apoptosis. Interestingly, the specific caspase-3
inhibitor Z-DEVD-FMK did not produce the same effect. A
cells were infected with BHV-4 at a m.o.i. of 10 PFU/cell (INFECTED)
intracellular Bcl-2 protein following permeabilization and staining with
levant control monoclonal antibody (FITC) was performed. The dashed
stained with irrelevant antibody and maintained in the corresponding
t experiments.S/BEK
lysis of
r an irresimple interpretation of these results is that caspases















35APOPTOSIS IN PERMISSIVE CELLS BY BHV-4caspase-7, could be activated in a caspase-3-indepen-
dent manner. Z-VAD-FMK, acting upstream in caspase
cascade activation (Cohen, 1997), could in any case
block virus-induced apoptosis, while Z-DEVD-FMK, act-
ing downstream specifically on caspase-3, does not pro-
duce the same effect.
More complex explanations of our results, however,
cannot be excluded. The caspase cascade can be acti-
vated in both death-receptor-mediated and death-recep-
tor-independent apoptosis (Sun et al., 1999). Unfortu-
nately, the lack of related reagents in the bovine system
prevented us from investigating this aspect. Conversely,
the availability of an anti-human cross-reacting antibody
allowed us to verify that BHV-4-induced apoptosis was
associated with antiapoptotic Bcl-2 protein down-regula-
tion. The kinetics of Bcl-2 down-regulation overlaps that
of induction of apoptosis. This evidence suggests that
the presence of optimal levels of Bcl-2 could counteract
BHV-4-induced apoptosis and that Bcl-2 down-regula-
tion, occurring specifically or not following infection,
could be linked to induction of apoptosis. However, our
results do not allow us to fully understand the pathways
involved in BHV-4-induced apoptosis and further studies
are necessary.
Nevertheless, whatever the exact mechanism, our re-
sults could lead to a revision of the general dogma
claiming that apoptosis of infected cells and efficient
virus production cannot coexist. But how could this hap-
pen? One of the characteristics of herpesviruses seems
FIG. 9. Effect of synthetic, cell-permeable caspase inhibitors on ap
Z-VAD-FMK and Z-DEVD-FMK, peptide analogs of caspase substrates, w
cells infected with LVR 140 at a m.o.i. of 10 PFU/cell immediately after
the percentage of cells showing nuclear morphology of apoptosis using
Results from one of the three experiments performed with similar resu
and left untreated or treated daily with Z-VAD-FMK or DMSO at the con
mM immediately after removing virus inoculum, and at half dose dur
infected control cells (control) or from cells infected and treated with Z-
assay. Data obtained from triplicate samples are expressed as mean
tested.to be that nucleocapsids bud through the nuclear mem-
brane, where they acquire their envelope and tegument
c
oto become mature virions. Viruses belonging to other
families complete these last phases of their replicative
cycles at the external membrane level. Modifications in
the inner nuclear membrane occur only during late
stages of apoptosis, as also recently shown (Duband-
Goulet et al., 1998), while those involving the external
membrane occur very rapidly once apoptosis has been
triggered. As a consequence, it can be hypothesized that
members of the Herpesviridae family selected the pecu-
liar final phase of their replicative cycle to escape, at
least in part, the aspecific host-defense mechanisms
represented by the triggering of apoptosis in virus-in-
fected cells. Thus, mature, fully infective virions could be
released by herpesviruses even from apoptosis-under-
going cells, or eventually, transmitted to apoptotic bodies
capturing phagocytes. BHV-4, as well as other g-2-her-
esviruses, could have selected a replication strategy, in
hich apoptosis of infected cells at a late stage of
nfection, which had its protective effect toward the host,
as converted into an efficient mechanism of virus
pread. The absence of an inflammatory response,
hich is associated in vivo with cell death by necrosis
ut not with apoptosis, could provide the virus with a
ubtle trick to escape host defense and to facilitate its
ersistence. Relevant to this is the new and interesting
inding that exposure to necrotic cells, in addition to
resentation of peptides on the cell surface, induces
ctivation in dendritic cells, while exposure to apoptotic
ells does not trigger expression of costimulatory mole-
and on virus yield in permissive cells following BHV-4 infection. (A)
ded at various concentrations to uninfected BS/BEK cells or to BS/BEK
ing virus inoculum. At 48 h p.i. apoptosis was detected by calculating
cence microscopy analysis of cells after staining with acridine orange.
shown. (B) BS/BEK cells were infected with BHV-4 as described in (A)
tion present in the diluent. Z-VAD-FMK was added at a full dose of 50
following days. Virus yield released in supernatants from untreated
K (Z-VAD-FMK) or DMSO (DMSO), respectively, was titrated by plaque







VAD-FMules in these cells (Sauter et al., 2000). In the absence































36 SCIORTINO ET AL.of viral antigens by dendritic cells could lead to a se-
lected inactivation of specific T cells rather than to their
activation.
In conclusion, our results demonstrate a virus inocu-
lum-dependent and time-dependent induction of apopto-
sis in cells productively infected by BHV-4 in vitro. As a
onsequence, we identified as “apoptotic infection” that
aused by BHV-4 in permissive cell lines. Finally, the
vailability of the experimental model of apoptotic BHV-4
nfection in vitro could also be useful for future identifi-
ation of viral genes involved in the control of apoptosis
y other g-2-herpesviruses for which productive infection
n vitro represents a serious problem.
MATERIALS AND METHODS
Viruses, cells, and treatments
The LVR 140 reference strain of BHV-4 (kindly provided
by Dr. M. Luini) was used in most of the experiments. In
some experiments a field isolate, designated as BHV-4/
FI, deriving from a bovine affected by postpartum metritis
(characterized and kindly provided by Dr. C. Buonavoglia,
University of Bari, Italy), was utilized. Virus stocks were
produced by infecting cultures of BS/BEK cells (Ferrari et
al., 1991), originally obtained from the Istituto Zooprofi-
lattico Sperimentale (Brescia, Italy), propagated in com-
plete medium (CM) consisting of Eagle’s MEM (HyClone
Europe, Cramlington, UK) containing 10% fetal calf serum
(FCS; Life Technologies, Gaithersburg, MD), 5 mM L-
lutamin, 100 U/ml penicillin, and 100 mg/ml streptomy-
in, at 37°C in a CO2 incubator. This cell line, as well as
he AU-BEK (Rossi and Kiesel, 1973) and the Madin–
arby bovine kidney (MDBK, originally obtained from
TCC, Rockville, MD) cell lines that were used in some
xperiments, were all characterized by productive infec-
ion by BHV-4, and were found to be free of mycoplasma
nd bovine viral diarrhea virus. After 72 h of infection, cell
xtracts, obtained by three cycles of freezing and thaw-
ng, were pooled, collected, and stored in aliquots at
80°C. The virus-containing cell-extract stocks were
uccessively tested and gave a titer of 1 3 108 PFU/ml in
BS/BEK cells 7 days after infection. For experimental
infections, 24 h after cultures had been split, cells grown
to approximately 80% confluency were inoculated in CM
with BHV-4 at different PFU/cell ratios and incubated at
37°C in 5% CO2. Control cultures were inoculated with
equivalent quantities of medium only. Alternatively, for
mock infection, target cells were exposed to control
cellular extracts collected from uninfected BS/BEK cells,
manipulated, and then stored in the same way as those
containing the virus. At 1 h p.i., medium containing virus
inoculum was removed from the cultures to which fresh
CM was then added for the remaining culture time.
Uninfected, BHV-4-infected, and mock-infected cells
were grown at 37°C in CM. In experiments requiring
inactivated virus, virus suspensions were placed in
c
P35-mm petri dishes and, in constant agitation, a volume
of 1 ml was exposed for varying times to UV light at an
intensity of 30 W from a germicidal lamp situated 19 cm
above the sample.
Phosphonoacetic acid (PAA; Sigma, St. Louis, MO)
was added after removing virus inoculum, together with
CM, at doses from 18.7 to 300 mg/ml. The higher con-
centration utilized completely inhibited virus replication,
while only slightly affecting cell viability in preliminary
experiments.
In caspase-inhibition experiments, Z-VAD-FMK and Z-
DEVD-FMK (Calbiochem, San Diego, CA) cell-permeable
peptide analogs of caspase substrates were added to
infected and control cultures at concentrations ranging
from 12.5 to 100 mM.
Productive infection was detected by titrating extracel-
lular or total virus from experimental cultures. Virus titers
were determined by plaque assay on BS/BEK cells, as
previously described for determining titers of virus
stocks.
In some experiments, necrosis was induced in BS/BEK
cells by heat-shock treatment at 60°C for 1 h in a water
bath.
Evaluation of apoptosis
At different times following infection, adherent cells,
removed from the culture substrate by treatment with
trypsin-EDTA solution, were again mixed with cells pre-
viously collected by centrifugation in supernatant from
the same flask and resuspended at an adequate con-
centration in PBS. Thus, the entire cell population of the
culture was reconstituted and processed for further anal-
ysis. The percentage of apoptotic cells from infected or
control cultures was then evaluated using different tech-
niques. Morphological analysis, following staining with
acridine orange or Hoechst chromatin dyes, was per-
formed as previously described (Mastino et al., 1997).
riefly, a minimum of 600 cells, including those showing
poptotic characteristics, were counted using a fluores-
ence microscope (Biomed, Leitz, Wetzlar, Germany).
he identification of apoptotic cells was based on the
resence of uniformly stained nuclei showing chromatin
ondensation and nuclear fragmentation. The percent-
ge of apoptotic cells was calculated as follows:
% apoptosis
5
Total no. of cells with apoptotic nuclei
Total no. of cells counted
3 100.
low cytometry analysis of isolated nuclei was per-
ormed using a method that we recently described for
ymphoid cells, which distinguishes apoptosis from ne-
rosis and viability (Matteucci et al., 1999). Briefly, cells
ollected as previously described were washed twice in















































37APOPTOSIS IN PERMISSIVE CELLS BY BHV-4inson Labware, Lincoln Park, NJ). The cell pellet was
immediately resuspended gently at room temperature in
1 ml of hypotonic solution consisting of 50 mg/ml pro-
idium iodide (Becton Dickinson, Mountain View, CA),
.1% sodium citrate (Merck, Darmstadt, Germany), and
% Triton X-100 (Sigma) in distilled water. The tubes were
laced at 4°C in the dark overnight. Flow cytometry
nalysis was subsequently performed using a FACscan
low cytometer (Becton Dickinson). A correct threshold
alue was experimentally selected to exclude the major-
ty of cell debris. Data collection was gated using ade-
uate values of forward- and side-angle scatter to ex-
lude remaining cell debris and large nuclei aggregates,
nd to include nuclei from apoptotic, necrotic, and living
ells. For each sample 5000 events were acquired. Di-
ect analysis of DNA fragmentation was carried out at the
ingle-cell level using the TUNEL technique. Labeling of
NA strand breaks with fluorescein-dUTP by terminal
eoxynucleotidyl transferase was performed using a
ommercial kit (In situ cell death detection kit, fluores-
ein; Boehringer Mannheim, Mannheim, Germany) ac-
ording to the manufacturer’s instructions. Positive con-
rol consisted of cells treated with DNase I (1 mg/ml) for
0 min at room temperature. Analysis of labeled cells
as performed by either fluorescence microscopy or
low cytometry. For flow cytometry, labeled cells were
cquired and analyzed on a FACScan (Becton Dickinson)
sing the FACScan program (Becton Dickinson), follow-
ng adequate gating by scatter parameters to exclude
ell debris and large cell aggregates, and to include
resumably apoptotic, necrotic, and living cells. For each
ample, 5000 events were acquired.
mmunofluorescence
To analyze Bcl-2 expression by flow cytometry, cells
ollected as previously described were transferred at
3 106 cells/sample to 12 3 75-mm polystrene tubes
(Falcon/Becton Dickinson Labware). Cell pellets were
fixed in 4% paraformaldehyde in PBS (pH 7.4) for 20 min
at room temperature in a total volume of 0.5 ml. A volume
of 1 ml of 0.1% Triton X-100 in PBS with 0.1% FCS was
then added and left for 5 min. After washing twice in PBS
with 3% FCS, permeabilized cells were incubated with a
fluorescein-conjugated monoclonal antibody against hu-
man Bcl-2 (clone 124; Dako, Copenhagen, Denmark) or
with an isotype control fluorescein-conjugated antibody
of unknown, irrelevant specificity (clone MOPC-21,
mouse IgG1,k; BD, Pharmingen, San Diego, CA) for 30
min on ice and washed twice in PBS with 0.1% sodium
azide. Preliminary experiments proved this anti-human
Bcl-2 antibody to react with bovine cells. Stained cells
were acquired and analyzed on a FACScan (Becton Dick-
inson) as previously described for the TUNEL technique.
For detection of viral proteins by fluorescence micros-
copy, without simultaneous analysis of apoptosis, afterwashing in PBS, cells were transferred to a multiwell
slide for immunofluorescence (about 1 3 104 cells/well;
ioMerieux, Marcy l’Etoile, France) and allowed to dry
efore fixing and permeabilizing for 5 min in acetone at
20°C. Samples were blocked with PBS containing 3%
CS. Staining of cells was then performed in a wet
hamber for 1 h at 37°C with a fluorescein-conjugated
ommercial monoclonal antibody, specific for BHV-4 pro-
eins (dilution, 1:20 in PBS, plus Evans blue solution;
io-x, Brussels, Belgium). For double-fluorescence mi-
roscopy analysis, to detect both virus protein and apop-
osis, cells fixed and permeabilized as previously de-
cribed for the analysis of Bcl-2 expression were stained
y the simultaneous addition of the fluorescein-conju-
ated monoclonal antibody specific for BHV-4 and the
NA-binding dye Hoechst (50 mg/ml), without the addi-
tion of Evans blue solution.
Statistical analysis
Data analysis was performed using the SPSS statisti-
cal software system (version 6.0 for Windows; SPSS,
Chicago, IL). Comparisons of means were carried out
using the Duncan test, as a multiple range test with 0.05
significance level.
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